RIGL

$0.00

(

0.00%

)
Quote details

stock

Rigel Pharmaceuticals Inc

NASDAQ | RIGL

28.63

USD

$0.00

(

0.00%

)

At Close (As of Sep 26, 2025)

$513.55M

Market Cap

5.27

P/E Ratio

5.43

EPS

$43.72

52 Week High

$13.57

52 Week Low

HEALTHCARE

Sector

RIGL Chart

Recent Chart
Price Action

RIGL Technicals

Tags:

RIGL Earnings

Yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit $161M
Total Revenue $179M
Cost Of Revenue $19M
Costof Goods And Services Sold $19M
Operating Income $24M
Selling General And Administrative $113M
Research And Development $23M
Operating Expenses $136M
Investment Income Net -
Net Interest Income -$5.8M
Interest Income $2.1M
Interest Expense $7.9M
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $2.2M
Income Before Tax $18M
Income Tax Expense $881K
Interest And Debt Expense -
Net Income From Continuing Operations $17M
Comprehensive Income Net Of Tax -
Ebit $26M
Ebitda $29M
Net Income $17M

Revenue & Profitability

Earnings Performance

RIGL Financials

yearly Balance Sheet (As of Dec 31, 2024)

Field Value (USD)
Total Assets $164M
Total Current Assets $135M
Cash And Cash Equivalents At Carrying Value $57M
Cash And Short Term Investments $57M
Inventory $6M
Current Net Receivables $42M
Total Non Current Assets $29M
Property Plant Equipment -
Accumulated Depreciation Amortization Ppe -
Intangible Assets $27M
Intangible Assets Excluding Goodwill $27M
Goodwill -
Investments -
Long Term Investments -
Short Term Investments $21M
Other Current Assets $10M
Other Non Current Assets -
Total Liabilities $161M
Total Current Liabilities $63M
Current Accounts Payable $3.3M
Deferred Revenue -
Current Debt -
Short Term Debt $7.6M
Total Non Current Liabilities $97M
Capital Lease Obligations $285K
Long Term Debt $52M
Current Long Term Debt $7.3M
Long Term Debt Noncurrent -
Short Long Term Debt Total $60M
Other Current Liabilities $51M
Other Non Current Liabilities $45M
Total Shareholder Equity $3.3M
Treasury Stock -
Retained Earnings -$1.4B
Common Stock $18K
Common Stock Shares Outstanding $18M

yearly Cash Flow (As of Dec 31, 2024)

Field Value (USD)
Operating Cashflow $31M
Payments For Operating Activities -
Proceeds From Operating Activities -
Change In Operating Liabilities -
Change In Operating Assets -
Depreciation Depletion And Amortization $2.2M
Capital Expenditures $36K
Change In Receivables -
Change In Inventory $764K
Profit Loss -
Cashflow From Investment $4.1M
Cashflow From Financing -$12M
Proceeds From Repayments Of Short Term Debt -
Payments For Repurchase Of Common Stock -
Payments For Repurchase Of Equity -
Payments For Repurchase Of Preferred Stock -
Dividend Payout -
Dividend Payout Common Stock -
Dividend Payout Preferred Stock -
Proceeds From Issuance Of Common Stock -
Proceeds From Issuance Of Long Term Debt And Capital Securities Net -
Proceeds From Issuance Of Preferred Stock -
Proceeds From Repurchase Of Equity -$10M
Proceeds From Sale Of Treasury Stock -
Change In Cash And Cash Equivalents -
Change In Exchange Rate -
Net Income $17M

yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit $161M
Total Revenue $179M
Cost Of Revenue $19M
Costof Goods And Services Sold $19M
Operating Income $24M
Selling General And Administrative $113M
Research And Development $23M
Operating Expenses $136M
Investment Income Net -
Net Interest Income -$5.8M
Interest Income $2.1M
Interest Expense $7.9M
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $2.2M
Income Before Tax $18M
Income Tax Expense $881K
Interest And Debt Expense -
Net Income From Continuing Operations $17M
Comprehensive Income Net Of Tax -
Ebit $26M
Ebitda $29M
Net Income $17M

RIGL News

RIGL Profile

Rigel Pharmaceuticals Inc Profile

Sector: HEALTHCARE

Industry: BIOTECHNOLOGY

Rigel Pharmaceuticals, Inc. is a biotechnology company based in South San Francisco, California, specializing in the discovery and development of novel small molecule drugs aimed at addressing critical unmet medical needs in blood disorders, cancer, and rare immune diseases. With a strong focus on innovative therapies, Rigel leverages its proprietary drug development platform to advance its pipeline of targeted treatments, aiming to improve patient outcomes in challenging therapeutic areas. The company is committed to addressing significant health challenges through scientific innovation and strategic partnerships within the healthcare sector.

DVLT
+30.57%
$1.09
INTC
+4.44%
$35.50
GPUS
+19.56%
$0.45
CGBS
-39.47%
$0.03
DFLI
+38.45%
$0.52
YAAS
-31.07%
$0.06
SNAP
-0.72%
$8.27
NEHC
+33.33%
$1.84
NUAI
+33.33%
$1.84
CJET
+10.63%
$0.17
NVDA
+0.28%
$178.19
F
+3.35%
$12.01
PSTV
+9.60%
$0.61
DNN
-3.14%
$2.77
APLT
+121.34%
$1.24
TSLA
+4.01%
$440.40
RGTI
-2.86%
$31.18
BIAF
+55.13%
$5.29
PLUG
+0.42%
$2.37
CIFR
-1.62%
$11.47
NIO
-5.75%
$7.04
ADAP
+15.74%
$0.14
WOK
-5.22%
$0.08
AAL
-0.70%
$11.31
RIG
+0.94%
$3.19
IONZ
+5.83%
$4.34
TPIC
-45.91%
$0.12
AXDX
-61.36%
$0.03
MRM
+102.75%
$2.94
QBTS
+1.59%
$26.76
VALE
-1.74%
$10.70
IREN
-9.57%
$41.86
BTG
+1.44%
$4.92
BLMZ
+12.51%
$0.20
QUBT
-2.11%
$20.14
MARA
+0.37%
$16.13
KVUE
+1.54%
$16.42
RIOT
+5.67%
$17.69
KDLY
+7.69%
$1.26
ATCH
-4.25%
$0.79
AAPL
-0.54%
$255.46
SOUN
-2.50%
$15.94
PLTR
-0.86%
$177.57
BITF
-5.22%
$2.54
BBD
+0.91%
$3.30
TLRY
-3.36%
$1.14
WBD
-1.36%
$19.51
AMZN
+0.74%
$219.78
FCX
+1.16%
$35.75
BURU
-10.14%
$0.12
BMNR
+1.87%
$50.50
IXHL
-0.01%
$0.59
ETHD
-6.19%
$3.94
RMBL
+60.50%
$3.21
RXRX
+1.94%
$4.72
SHOT
+12.24%
$0.28
RR
+2.68%
$4.20
GRAB
-2.24%
$6.11
ADD
-25.47%
$0.05
RAYA
-3.15%
$0.04
RIVN
-0.95%
$15.59
SOFI
-0.49%
$27.98
ONDS
-1.16%
$7.66
BULL
+3.55%
$15.16
CVE
+0.39%
$17.77
CLSK
-5.26%
$12.96
SRM
+53.27%
$10.30
ACHR
-0.53%
$9.27
PFE
+0.67%
$23.76
IONQ
-3.09%
$67.28
BB
+6.66%
$4.96
JOBY
+1.57%
$16.11
NOK
-0.42%
$4.66
AMD
-1.12%
$159.46
CRWV
-4.98%
$120.34
CLF
+2.48%
$12.37
CUTR
-10.19%
$0.09
PET
-59.91%
$0.04
BTE
+2.43%
$2.52
QS
+1.28%
$12.66
WLGS
-5.57%
$0.04
HIMS
+6.43%
$58.40
AQMS
+48.37%
$7.30
ABEV
0.00%
$2.29
MRVL
-0.76%
$83.17
ETWO
0.00%
$3.30
ORCL
-2.70%
$283.45
HBAN
+0.57%
$17.42
HOOD
-0.70%
$121.78
AG
+4.02%
$12.14
NWTN
-15.63%
$2.04
AIIO
-15.63%
$2.04
SDM
-86.40%
$1.85
T
+0.03%
$28.31
OKLO
-7.21%
$110.53
ITUB
+0.55%
$7.24
MU
+0.28%
$157.27
PCG
+3.67%
$14.97
AFMD
-34.94%
$0.18
WULF
-1.27%
$10.83
DVLT
+30.57%
$1.09
INTC
+4.44%
$35.50
GPUS
+19.56%
$0.45
CGBS
-39.47%
$0.03
DFLI
+38.45%
$0.52
YAAS
-31.07%
$0.06
SNAP
-0.72%
$8.27
NEHC
+33.33%
$1.84
NUAI
+33.33%
$1.84
CJET
+10.63%
$0.17
NVDA
+0.28%
$178.19
F
+3.35%
$12.01
PSTV
+9.60%
$0.61
DNN
-3.14%
$2.77
APLT
+121.34%
$1.24
TSLA
+4.01%
$440.40
RGTI
-2.86%
$31.18
BIAF
+55.13%
$5.29
PLUG
+0.42%
$2.37
CIFR
-1.62%
$11.47
NIO
-5.75%
$7.04
ADAP
+15.74%
$0.14
WOK
-5.22%
$0.08
AAL
-0.70%
$11.31
RIG
+0.94%
$3.19
IONZ
+5.83%
$4.34
TPIC
-45.91%
$0.12
AXDX
-61.36%
$0.03
MRM
+102.75%
$2.94
QBTS
+1.59%
$26.76
VALE
-1.74%
$10.70
IREN
-9.57%
$41.86
BTG
+1.44%
$4.92
BLMZ
+12.51%
$0.20
QUBT
-2.11%
$20.14
MARA
+0.37%
$16.13
KVUE
+1.54%
$16.42
RIOT
+5.67%
$17.69
KDLY
+7.69%
$1.26
ATCH
-4.25%
$0.79
AAPL
-0.54%
$255.46
SOUN
-2.50%
$15.94
PLTR
-0.86%
$177.57
BITF
-5.22%
$2.54
BBD
+0.91%
$3.30
TLRY
-3.36%
$1.14
WBD
-1.36%
$19.51
AMZN
+0.74%
$219.78
FCX
+1.16%
$35.75
BURU
-10.14%
$0.12
BMNR
+1.87%
$50.50
IXHL
-0.01%
$0.59
ETHD
-6.19%
$3.94
RMBL
+60.50%
$3.21
RXRX
+1.94%
$4.72
SHOT
+12.24%
$0.28
RR
+2.68%
$4.20
GRAB
-2.24%
$6.11
ADD
-25.47%
$0.05
RAYA
-3.15%
$0.04
RIVN
-0.95%
$15.59
SOFI
-0.49%
$27.98
ONDS
-1.16%
$7.66
BULL
+3.55%
$15.16
CVE
+0.39%
$17.77
CLSK
-5.26%
$12.96
SRM
+53.27%
$10.30
ACHR
-0.53%
$9.27
PFE
+0.67%
$23.76
IONQ
-3.09%
$67.28
BB
+6.66%
$4.96
JOBY
+1.57%
$16.11
NOK
-0.42%
$4.66
AMD
-1.12%
$159.46
CRWV
-4.98%
$120.34
CLF
+2.48%
$12.37
CUTR
-10.19%
$0.09
PET
-59.91%
$0.04
BTE
+2.43%
$2.52
QS
+1.28%
$12.66
WLGS
-5.57%
$0.04
HIMS
+6.43%
$58.40
AQMS
+48.37%
$7.30
ABEV
0.00%
$2.29
MRVL
-0.76%
$83.17
ETWO
0.00%
$3.30
ORCL
-2.70%
$283.45
HBAN
+0.57%
$17.42
HOOD
-0.70%
$121.78
AG
+4.02%
$12.14
NWTN
-15.63%
$2.04
AIIO
-15.63%
$2.04
SDM
-86.40%
$1.85
T
+0.03%
$28.31
OKLO
-7.21%
$110.53
ITUB
+0.55%
$7.24
MU
+0.28%
$157.27
PCG
+3.67%
$14.97
AFMD
-34.94%
$0.18
WULF
-1.27%
$10.83

Charts powered by TradingView


Market data may be delayed by 15 minutes or more and is provided by financial exchanges or third-party providers. AfterPullback does not verify or guarantee its accuracy and assumes no responsibility to do so. This website is not operated by a licensed attorney, accountant, or financial advisor. Nothing on this site constitutes financial advice or replaces consultation with a qualified professional who understands your specific circumstances. Always consult a licensed financial advisor before making investment decisions.